These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2449147)

  • 1. Soluble antigens of vaccinia virus. Note I. Chemical and biological properties. Immunogenic capacity.
    Mihăilescu R; Olinescu A; Popa L; Stavri H; Iancu L
    Arch Roum Pathol Exp Microbiol; 1987; 46(1):35-46. PubMed ID: 2449147
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolation & characterization of immunogenic soluble antigens from vaccinia virus infected tissues.
    Singh LM; Pal SC
    Indian J Exp Biol; 1972 Mar; 10(2):94-100. PubMed ID: 4644881
    [No Abstract]   [Full Text] [Related]  

  • 3. In-vitro demonstration of cell-mediated immunity to vaccinia virus in man.
    Koszinowski U; Volkmann B; Thomssen R
    Z Immunitatsforsch Exp Klin Immunol; 1975 May; 148(5):451-61. PubMed ID: 171872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of antigenic analysis of soluble antigens of three strains of vaccinia virus by different serological techniques.
    Singh LM
    Indian J Exp Biol; 1972 Mar; 10(2):105-8. PubMed ID: 4118887
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of humoral immunity and induction of proliferating T lymphocytes in vaccinia virus-infected rabbits and rhesus macaques.
    Schäffner JW; Dittmer U; Otteken A; Coulibaly C; Bodemer W; Voss G; Hunsmann G
    Am J Vet Res; 1994 Sep; 55(9):1250-5. PubMed ID: 7802392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of skin resistance to vaccinia virus in rabbits by vaccinia-soluble early antigens.
    Ueda Y; Tagaya I
    J Exp Med; 1973 Nov; 138(5):1033-43. PubMed ID: 4744920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed hypersensitivity in vaccinia-infected mice. II. Resistance of peritoneal macrophages against vaccinia infection.
    Ueda S; Nozima T
    Acta Virol; 1973 Jan; 17(1):41-9. PubMed ID: 4405395
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune and non-immune macrophage resistance to the fibroma-myxoma virus complex.
    Tompkins WA; Rama Rao GV; Woan MC
    J Reticuloendothel Soc; 1975 Jul; 18(1):23-33. PubMed ID: 168379
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunogenicity of nonreplicating recombinant vaccinia expressing HLA-A201 targeted or complete MART-1/Melan-A antigen.
    Schütz A; Oertli D; Marti WR; Noppen C; Padovan E; Spagnoli GC; Heberer M; Zajac P
    Cancer Gene Ther; 2001 Sep; 8(9):655-61. PubMed ID: 11593334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behaviour of the typhoid vaccine intradermally administered in association with tetanus unadsorbed vaccine and soluble antigens of vaccinia virus.
    Croitoru M; Dimache G; Mihăilescu R; Velea V; Durbacă S; Stoean C
    Arch Roum Pathol Exp Microbiol; 1988; 47(2):139-43. PubMed ID: 3250365
    [No Abstract]   [Full Text] [Related]  

  • 11. [The immunogenic capacity of soluble "vaccinia" antigen (fractionated smallpox vaccine) administered simultaneously with inactivated typhoid vaccine and with purified and concentrated tetanus anatoxin].
    Mihăilescu R; Dimache G; Velea V; Stoean C; Croitoru M; Durbacă S; Chirescu N
    Arch Roum Pathol Exp Microbiol; 1989; 48(2):151-6. PubMed ID: 2699409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
    Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
    Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reaction of influenza viruses with thymus-dependent lymphocytes].
    Süss J; Schmidt S; Schmidt J
    Allerg Immunol (Leipz); 1982; 28(3):165-73. PubMed ID: 6183963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Some aspects of antibody response in newborn rats].
    Andrezejewski J
    Ann Acad Med Stetin; 1974; Suppl 11():5-68. PubMed ID: 4475475
    [No Abstract]   [Full Text] [Related]  

  • 15. Macrophage immunity to vaccina virus: factors affecting macrophage immunity in vitro.
    Schultz RM; Woan MC; Tompkins WA
    J Reticuloendothel Soc; 1974 Jul; 16(1):37-47. PubMed ID: 4137839
    [No Abstract]   [Full Text] [Related]  

  • 16. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
    Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
    J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The response of gut-associated T lymphocytes to intestinal viral immunization.
    Issekutz TB
    J Immunol; 1984 Dec; 133(6):2955-60. PubMed ID: 6333450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of surface antigen on cells infected by fibroma virus.
    Tompkins WA; Crouch NA; Tevethia SS; Rawls WE
    J Immunol; 1970 Nov; 105(5):1181-9. PubMed ID: 4321290
    [No Abstract]   [Full Text] [Related]  

  • 19. The immune response to infection with vaccinia virus in mice. II. Appearance of hypersensitivity, production of macrophage migration inhibitory factor and transformation of spleen cells in response to virus antigens.
    Hutt LM
    J Hyg (Lond); 1975 Jun; 74(3):315-27. PubMed ID: 1056960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune response of the rabbit to smallpox vaccines].
    Musetescu M
    J Biol Stand; 1974 Jul; 2(3):231-41. PubMed ID: 4372233
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.